INSIGHTS+ Insights+: The US FDA New Drug Approvals in February 2022BySenior EditorMarch 17, 20220Comments
VIEWPOINTS PharmaShots Interview: Clario’s Lynne Borthwick Shares Insight on Winning Top Workplace Award by EnergageBySenior EditorMarch 16, 20220Comments
VIEWPOINTS PharmaShots Interview: Dermavant’s Philip Brown Shares Insight on the P-III (PSOARING 3) Study of TapinarofBySenior EditorMarch 15, 20220Comments
VIEWPOINTS PharmaShots Interview: Jazz Pharmaceuticals’ Bruce C. Cozadd Shares Insight on Vision 2025 During the Virtual Presentation at 40th Annual J.P. Morgan Healthcare Conference 2022BySenior EditorMarch 14, 20220Comments
TOP 20 Top 20 Biopharma Deal Terminations of 2021 Based on Total Deal ValueByPrince GiriMarch 10, 20220Comments
VIEWPOINTS PharmaShots Interview: Guardant Health’s Kathryn Lang Shares Insight on SHIELD Blood Test for Colorectal CancerBySenior EditorMarch 9, 20220Comments
VIEWPOINTS PharmaShots Interview: SalioGen Therapeutics’ Ray Tabibiazar Shares Insights on Gene Coding PlatformBySenior EditorMarch 8, 20220Comments
